Braltus

Braltus is a medication containing tiotropium bromide, used for managing respiratory conditions. It is designed for oral use and is manufactured by Teva Pharma Belgium N.V./S.A.

Braltus is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It helps to improve breathing by relaxing the muscles in the airways. This medication is not intended for immediate relief of sudden breathing problems.

Common effects of Braltus may include dry mouth, constipation, and throat irritation. Some users might experience blurred vision or dizziness. These effects are generally mild and temporary, but persistent issues should be discussed with a healthcare provider.

Braltus should be used with caution in individuals with a history of urinary retention, narrow-angle glaucoma, or prostate problems. It is important to follow the prescribed dosage and administration instructions to minimize potential risks.

Braltus may interact with other medications, including anticholinergics and some antihistamines. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.